Allspring Global Investments Holdings, LLC C4 Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$5.42 - $10.24 $86 - $163
-16 Reduced 2.16%
725 $0
Q3 2022

Oct 26, 2022
SELL
$8.03 - $12.77 $11,193 - $17,801
-1,394 Reduced 65.29%
741 $6,000
Q2 2022

Jul 25, 2022
SELL
$5.06 - $26.46 $71,578 - $374,303
-14,146 Reduced 86.89%
2,135 $16,000
Q1 2022

May 02, 2022
BUY
$19.99 - $33.23 $12,273 - $20,403
614 Added 3.92%
16,281 $394,000
Q4 2021

Jan 28, 2022
BUY
$29.39 - $46.86 $460,453 - $734,155
15,667 New
15,667 $504,000

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $208M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email